THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE.
It is intended for informational
purposes only. It is not a substitute for professional medical advice,
diagnosis or treatment. Never ignore professional medical advice in seeking
treatment because of something you have read on the WebMD Site. If you think
you may have a medical emergency, immediately call your doctor or dial
1. Wilson, PW, D'Agostino, RB, Levy, D, et
al. Prediction of coronary heart disease using risk factor categories.
Circulation 1998; 97(18):1837-1847.
2. D'Agostino, RB Sr, Grundy, S, Sullivan,
LM, Wilson, P. Validation of the Framingham Coronary Heart Disease Prediction
Scores: results of a multiple ethnic group investigation.
JAMA 2001; 286(2):180-187.
3. Third report of the National Cholesterol
Education Program (NCEP) Expert Panel on detection, valuation, and treatment of
high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002;
4. Chobanian, AV, Bakris, GL, Black, HR,
Cushman, WC. The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure: The JNC7
Report. JAMA 2003; 289(19):3560-2572.
5. Ford, ES, Giles, WH, Mokdad, AH. The
distribution of 10-year risk for coronary heart disease among
US adults: findings from the National Health and Examination Survey
III. J Am Coll Cardiol 2004; 43(10):1791-1796.
6. Stampfer, MJ, Hu, FB, Manson, JE, Rimm,
EB, Willett, WC. Primary prevention of coronary heart disease in women through
diet and lifestyle. N Engl J Med 2000; 343(1):16-22.
7. Diabetes Mellitus Interagency
Coordinating Committee Meeting, National Institutes of Health Campus, Natcher
Conference Center, Conference Room A, Bethesda, Maryland, February 25, 2003.
The Metabolic Syndrome, Summary Minutes.
8. Harris, MI, Flegal, KM, Cowie, CC, et al.
Prevalence of diabetes, impaired fasting glucose, and impaired glucose
tolerance in U.S. adults: The Third National Health and Nutrition
Examination Survey, 1988-1994. Diabetes Care 1998; 21(4):518-524.
9. Heikes, KE, Eddy, DM. A simple tool for
detecting unrecognized prediabetes and diabetes. 2006. Prepared for
GlaxoSmithKline by Archimedes, Inc.
10. Pearson, TA, Blair, SN, Daniels, SR, et
al. AHA guidelines for primary prevention of cardiovascular disease and
stroke 2002 update: Consensus panel guide to comprehensive risk reduction
for adult patients without coronary or other atherosclerotic vascular diseases.
American Heart Association Science Advisory and Coordinating committee.
Circulation 2002; 106(3):388-391.
11. US Preventive Services Task Force.
Guide to clinical preventive services, 3rd ed. 2000-2002.
12. Law, MR, Morris, JK. By how much does
fruit and vegetable consumption reduce the risk of ischaemic heart
disease? Eur J Clin Nutr 1998; 52(8):549-556.
13. Gillman, MW, Cupples, LA, Gagnon, D, et
al. Protective effect of fruits and vegetables on development of stroke in men.
JAMA 1995; 273(14):1113-1117.
14. Manson, JE, Hu, FB, Rich-Edwards, JW, et
al. A prospective study of walking as compared with vigorous exercise in the
prevention of coronary heart disease in women. N Engl J Med 1999;
15. Hubert, HB, Feinleib, M, McNamara, PM,
Castelli, WP. Obesity as an independent risk factor for cardiovacular
disease: a 26-year follow-up of participants in the Framingham Heart
Study. Circulation 1983; 67(5):968-977.
16. UK Prospective Diabetes Study
(UKPDS) Group. Intensive blood-glucose control with sulphonylureas or
insulin compared with conventional treatment and risk of complications in
patients with type 2 diabetes (UKPDS33). Lancet 1998;
17. Nathan, DM, Cleary, PA, Backlund, JY, et
al. Intensive diabetes treatment and cardiovascular disease in patients with
type 1 diabetes. N Engl J Med 2005; 353(25):2643-2653.
18. Major outcomes in moderately
hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual
care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart
Attack Trial (ALLHAT-LLT). JAMA 2002; 288(23):2998-3007.
19. Sever, PS, Dahlof, B, Poulter, NR, et al.
Prevention of coronary and stroke events with atorvastatin in hypertensive
patients who have average or lower-than-average cholesterol concentrations, in
the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm
(ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;
20. HJ Schneider, et al.
Waist-to-tallness ratio (WTR) is the best antropometric indicator of
cardiovascular risk:Findings from the DETECT study. The Endocrine
Society's Annual Meeting. 2005
21. Cigarette smoking and health. The
official statement from the American Thoracic Society. Am J Respit Crit Care
Med 1996; 153:861-865.
22. Kaplan, GA, et al. Perceived health
status and morbidity and mortality: evidence from the Kuopio ischaemic
heart disease risk factor study. Int J Epidemiol 1996 Apr;